BRCA1 mutations occur at the highest rates in the RING domain, exons... | Download Scientific Diagram
Identification of BRCA1/2 Founder Mutations in Southern Chinese Breast Cancer Patients Using Gene Sequencing and High Resolution DNA Melting Analysis – topic of research paper in Biological sciences. Download scholarly article PDF
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status - The Lancet
Frontiers | A novel BRCA1 splicing variant detected in an early onset triple-negative breast cancer patient additionally carrying a pathogenic variant in ATM: A case report
Diagnostics | Free Full-Text | Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
🌸 Join BIC Services in Honouring Breast Cancer Awareness Month! | BIC Services posted on the topic | LinkedIn
The Breast Cancer Information Core: Database design, structure, and scope - Szabo - 2000 - Human Mutation - Wiley Online Library
BRCA1 and BRCA2 genes mutations among high risk breast cancer patients in Jordan | Scientific Reports
![PDF] Genotyping of BRCA 1 , BRCA 2 , p 53 , CDKN 2 A , MLH 1 and MSH 2 genes in a male patient with secondary breast cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c9be17e10dba17347d1fb8b769919e19ce0b43e8/2-Table1-1.png "PDF] Genotyping of BRCA 1 , BRCA 2 , p 53 , CDKN 2 A , MLH 1 and MSH 2 genes in a male patient with secondary breast cancer | Semantic Scholar")
PDF] Genotyping of BRCA 1 , BRCA 2 , p 53 , CDKN 2 A , MLH 1 and MSH 2 genes in a male patient with secondary breast cancer | Semantic Scholar
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2 | PLOS Genetics
Correlation between mutation testing and immunohistochemistry | Download Table
The Breast Information Core (BIC) Website Features. Overview and map of... | Download Scientific Diagram
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Table 2 from Suggestion of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown significance' to 'Likely pathogenic' based on clinical evidence in Korea. | Semantic Scholar
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Oncology
Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2 – topic of research paper in Biological sciences. Download scholarly article PDF and read for free on
Germline sequence variants contributing to cancer susceptibility in South African breast cancer patients of African ancestry | Scientific Reports
Links
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text
BRCA1/2 testing: therapeutic implications for breast cancer management | British Journal of Cancer
PDF) The Breast Cancer Information Core: Database design, structure, and scope
Genes | Free Full-Text | Imprecise Medicine: BRCA2 Variants of Uncertain Significance (VUS), the Challenges and Benefits to Integrate a Functional Assay Workflow with Clinical Decision Rules
Abbreviation: BIC, Breast Cancer Information Core database. a GenBank... | Download Scientific Diagram
KoreaMed Synapse
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer | Nature Communications
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals | Breast Cancer Research | Full Text
